ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement

Naoki Ikenaga, Yoshihiro Miyasaka, Takao Ohtsuka, Masafumi Nakamura

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

!!!All Science Journal Classification (ASJC) codes

この成果は、次の持続可能な開発目標に貢献しています

@article{b82aa4f7197340f69a6c880a1a284168,

title = "ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement",

author = "Naoki Ikenaga and Yoshihiro Miyasaka and Takao Ohtsuka and Masafumi Nakamura",

year = "2022",

doi = "10.1245/s10434-022-12584-z",

language = "English",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement

AU - Ikenaga, Naoki

AU - Miyasaka, Yoshihiro

AU - Ohtsuka, Takao

AU - Nakamura, Masafumi

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85138507731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138507731&partnerID=8YFLogxK

U2 - 10.1245/s10434-022-12584-z

DO - 10.1245/s10434-022-12584-z

M3 - Comment/debate

C2 - 36131116

AN - SCOPUS:85138507731

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -